Literature DB >> 12811678

Low serum total thyroxine and free triiodothyronine in patients with hepatic encephalopathy due to non-alcoholic cirrhosis.

Ertuğrul Kayacetin1, Gurcan Kisakol, Ahmet Kaya.   

Abstract

PRINCIPLES: We evaluated serum thyroid hormone levels in non-alcoholic cirrhotic patients with and without hepatic encephalopathy.
METHODS: 15 consecutive patients with hepatic encephalopathy secondary to non-alcoholic cirrhosis (8 males and 7 females, age 37-75 years) and 33 non-alcoholic cirrhotic patients without encephalopathy (22 males and 11 females, age 36-74 years) were investigated. A control group consisted of 20 healthy subjects (10 men and 10 women aged 26-69 years). The levels of serum triiodothyronine (T3), thyroxine (T4), thyrotropin (TSH), free T3 (FT3) and free T4 (FT4) were studied in serum samples drawn in the morning. Thyroid function tests were set in relation to the severity of hepatic dysfunction and to the presence or absence of hepatic encephalopathy.
RESULTS: Serum levels of FT3 and total T4 (but not total T3 and FT4) were significantly lower in patients with hepatic encephalopathy compared to decompensated cirrhotic patients without encephalopathy (p = 0.006 for T4, P <0.05 for FT3). Prothrombin-time also differed significantly between decompensated cirrhotic patients (Child C) with and without encephalopathy groups (p = 0.002).
CONCLUSIONS: These results suggest that patients with hepatic encephalopathy secondary to decompensated non-alcoholic cirrhosis are typified by low FT3 and low total T4, as well as by a prolonged prothrombin time. Low FT3 does not obviously put patients at risk for hepatic encephalopathy, and thyroid parameters are secondary and late events.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12811678     DOI: 2003/13/smw-10172

Source DB:  PubMed          Journal:  Swiss Med Wkly        ISSN: 0036-7672            Impact factor:   2.193


  5 in total

1.  Thyroid hormones alterations during acute liver failure: possible underlying mechanisms and consequences.

Authors:  Georgia Kostopanagiotou; Konstantinos Kalimeris; Iordanis Mourouzis; Konstantinos Kostopanagiotou; Nikolaos Arkadopoulos; Dimitrios Panagopoulos; Nikolaos Papoutsidakis; Aikaterini Chranioti; Agatha Pafiti; Danai Spanou; Vassilios Smyrniotis; Constantinos Pantos
Journal:  Endocrine       Date:  2009-06-19       Impact factor: 3.633

2.  Transcriptome Profile of Thyroid Glands in Bile Duct Ligation Mouse Model.

Authors:  Danbi Jo; Hee Kyung Kim; Young-Kook Kim; Juhyun Song
Journal:  Int J Mol Sci       Date:  2022-07-26       Impact factor: 6.208

3.  The abnormality of thyroid hormones in patients with type A hepatic encephalopathy.

Authors:  Lin Wang; Wanyou Yu; Wukui Cao; Wei Lu
Journal:  Oncotarget       Date:  2017-06-29

4.  A Study of Thyroid Dysfunction in Cirrhosis of Liver and Correlation with Severity of Liver Disease.

Authors:  P Punekar; Ashvanee Kumar Sharma; A Jain
Journal:  Indian J Endocrinol Metab       Date:  2018 Sep-Oct

5.  Evaluation of Predisposing Metabolic Risk Factors for Portopulmonary Hypertension in Patients with NASH Cirrhosis.

Authors:  Fatih Türker; Tolga Sahın; Alihan Oral; Erdem Koçak; Betül Çavuşoğlu Türker; Adil Niğdelioğlu; Hayriye Esra Ataoğlu
Journal:  Int J Gen Med       Date:  2022-01-25
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.